These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 4328514)

  • 1. [Dosage schedule of new anticancer drugs--evaluation of the use of 3 anticancer drugs in the study of phases 1 and 2].
    Saito T; Oira S; Wakui A; Yokoyama M; Himori T
    Gan No Rinsho; 1971 Aug; 17(8):589-98. PubMed ID: 4328514
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical experience with a new anticancer agent, carbazilquinone].
    Saito T; Oira S; Wakui A; Yokoyama M; Takahashi H
    Gan No Rinsho; 1971 Nov; 17(11):806-18. PubMed ID: 4947602
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased lifespan using the priming dose schedule design in carbazilquinone (NSC-134679) treatment of mouse leukemia L1210.
    Straus MJ; Goldin A
    Cancer Chemother Rep; 1972 Feb; 56(1):19-23. PubMed ID: 5030804
    [No Abstract]   [Full Text] [Related]  

  • 4. Regional perfusion and circulation-stop method for chemotherapy of cancer and metastasis.
    Baba T; Kimura NT; Kanematsu T; Aoki K
    Gan; 1974 Jun; 65(3):285-7. PubMed ID: 4854067
    [No Abstract]   [Full Text] [Related]  

  • 5. Complete inhibition of mouse lymphoid leukemia L-1210 by carbazilquinone.
    Arakawa M
    Gan; 1972 Aug; 63(4):487-9. PubMed ID: 5081624
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical experience with a new anticancer agent, carbazilquinone (NSC-134679).
    Saito T; Oira S; Wakui A; Yokoyama M; Takahashi H
    Cancer Chemother Rep; 1973; 57(4):447-57. PubMed ID: 4586952
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of carbazilquinone on lymphoid leukemia L-1210.
    Arakawa M; Aoki T; Nakao H
    Gan; 1970 Oct; 61(5):485-93. PubMed ID: 5476838
    [No Abstract]   [Full Text] [Related]  

  • 8. Preclinical toxicity studies of kahalalide F, a new anticancer agent: single and multiple dosing regimens in the rat.
    Brown AP; Morrissey RL; Faircloth GT; Levine BS
    Cancer Chemother Pharmacol; 2002 Oct; 50(4):333-40. PubMed ID: 12357309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I study of SOAz.
    Nasca S; Jezekova D; Coninx P; Garbe E; Carpentier Y; Cattan A
    Cancer Treat Rep; 1982 Dec; 66(12):2039-42. PubMed ID: 7139646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aminothiadiazole: an antineoplastic thiadiazole.
    O'Dwyer PJ; Wagner BH; Stewart JA; Leyland-Jones B
    Cancer Treat Rep; 1986 Jul; 70(7):885-9. PubMed ID: 2872957
    [No Abstract]   [Full Text] [Related]  

  • 11. Induction of dominant lethals in mice by TEPA and HEMPA.
    Srám RJ; Benes V; Zudová Z
    Folia Biol (Praha); 1970; 16(6):407-15. PubMed ID: 5479796
    [No Abstract]   [Full Text] [Related]  

  • 12. Grouping of anticancer drugs based on administration method-related toxicity patterns in rats.
    Mizushima Y; Li H; Sassa K; Fujishita T; Oosaki R; Kobayashi M
    Anticancer Res; 1997; 17(6D):4611-4. PubMed ID: 9494577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of ifosfamid with cyclophosphamide in the therapy of rat DS carcinosarcoma].
    von Ardenne M; Reitnauer PG; Rohde K
    Arch Geschwulstforsch; 1971; 38(1):15-26. PubMed ID: 4334130
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative evaluation of the effectiveness of radioprotective agents judged from their protection of bone marrow and the gastrointestinal tract].
    Piatovskaia NN; Brumberg IE
    Radiobiologiia; 1982; 22(2):183-6. PubMed ID: 7092996
    [No Abstract]   [Full Text] [Related]  

  • 15. [The dependence of the antineoplastic activity of serotonin on dose and route of administration].
    Mal'tseva LF
    Vopr Onkol; 1966; 12(3):67-71. PubMed ID: 5991964
    [No Abstract]   [Full Text] [Related]  

  • 16. Toxicity of aziridinylbenzoquinone administered Iv to beagle dogs.
    Hacker MP; Hong CB; McKee MJ; Unwin SE; Urbanek MA
    Cancer Treat Rep; 1982 Oct; 66(10):1845-51. PubMed ID: 7127322
    [No Abstract]   [Full Text] [Related]  

  • 17. [Toxicological and teratological study of a hypocholesterolemiant (MG. 46)].
    Da Lage C; Labie C; Loiseau G; Lohier P; Marquet JP; Truchaud M
    Eur J Toxicol; 1972; 5(4):239-53. PubMed ID: 4649399
    [No Abstract]   [Full Text] [Related]  

  • 18. [New antineoplastic agents].
    Saito T
    Naika; 1971 Oct; 28(4):665-71. PubMed ID: 4943165
    [No Abstract]   [Full Text] [Related]  

  • 19. Phase II clinical evaluation of AZQ in colorectal cancer.
    Bedikian AY; Stroehlein JR; Karlin DA; Korinek J; Bodey GP
    Am J Clin Oncol; 1982 Oct; 5(5):535-7. PubMed ID: 7180831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influencing of side-effects of cytostatic drugs using metoclopramide].
    Hartwich G
    Munch Med Wochenschr; 1973 Apr; 115(16):714-6. PubMed ID: 4351982
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.